Immunohistological study of islet xenograft rejection in immunosuppressed recipients.
Andereggen
E
E
Department of Surgery, University Hospital of Geneva, Switzerland.
Bühler
L
L
Fournier
B
B
Deng
S
S
Bubloz
C
C
Morel
P
P
D000818:Animals; D017252:CD3 Complex / Q000032:analysis; D015704:CD4 Antigens / Q000032:analysis; D016827:CD8 Antigens / Q000032:analysis; D016572:Cyclosporine / Q000627:therapeutic use; D003921:Diabetes Mellitus, Experimental / Q000601:surgery*; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D006146:Guanidines / Q000627:therapeutic use; D007136:Immunoglobulins / Q000032:analysis; D007150:Immunohistochemistry; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016381:Islets of Langerhans Transplantation / Q000276:immunology / Q000473:pathology*; D016177:Macrophage-1 Antigen / Q000032:analysis; D051379:Mice; D008810:Mice, Inbred C57BL; D051381:Rats; D017207:Rats, Sprague-Dawley; D015375:Receptors, Interleukin-2 / Q000032:analysis; D016559:Tacrolimus / Q000494:pharmacology; D014183:Transplantation, Heterologous / Q000276:immunology / Q000473:pathology*
D017252:CD3 Complex; D015704:CD4 Antigens; D016827:CD8 Antigens; D006146:Guanidines; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D016177:Macrophage-1 Antigen; D015375:Receptors, Interleukin-2; D016572:Cyclosporine; C037258:gusperimus; D016559:Tacrolimus